Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Blood coagulation factors;von Willebrand factor and coagulation factor VIII in combination;Antihemorrhagics

Voncento

(human coagulation factor VIII / human von willebrand factor)

Uses, side effects, dosage information & price range

CSL Behring GmbH

About this medicine

Von Willebrand disease (VWD) Prophylaxis and treatment of haemorrhage or surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital factor-VIII deficiency) Prophylaxis and treatment of bleeding in patients with haemophilia A.

Common Brand Names for this Composition

The following popular commercial brand names contain human coagulation factor VIII / human von willebrand factor as their active ingredient composition:

Voncento

CSL Behring GmbH

MRPPrice on Request

Key Information

Salt / Composition

human coagulation factor VIII / human von willebrand factor